Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Yvon Kenis"'
Publikováno v:
Acta clinica Belgica. 22(6)
Direct Coombs tests were performed in 265 patients with solid tumors, leu-kemias and malignant lymphomas. The frequency of highly positive Coombs tests varied from 5.52 in the solid tumors (13 % for the carcinomas) to 52 % in chronic lymphotic leukem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e0189ccb174b9ea390d11c27bb4d72d
https://pubmed.ncbi.nlm.nih.gov/27351785
https://pubmed.ncbi.nlm.nih.gov/27351785
Publikováno v:
European Journal of Cancer. 40:1918-1923
Resume Quatre-vingt-quatorze cos de tumeurs solides ont ete traites par le Natulan. Un effet objectif certain a ete observe dans 3 cas d'epithelioma de la tete et du cou, 3 cas de cancer du poumon, 1 cas de carcinome de l'ovaire, 1 cas de carcinome d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::448f9986bfc417d17e0819a296606cdc
https://doi.org/10.1016/j.ejca.2004.05.016
https://doi.org/10.1016/j.ejca.2004.05.016
Publikováno v:
Tumori Journal. 63:299-302
Six intracarotid artery infusions of DTIC were performed in 4 patients with invasive malignant melanoma of the maxillo-facial region. A total dose of 3.5 to 7 g was well tolerated. Only 1 patient who received 9.5 g in 25 days developed a reversible b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f4194891b17cafd13f43ac9434514b9
https://doi.org/10.1177/030089167706300308
https://doi.org/10.1177/030089167706300308
Autor:
M.M. Kitt, William Rombaut, Yvon Kenis, Marcel Rozencweig, Pierre Dodion, Charlotte Sanders, Jean Klastersky
Publikováno v:
European Journal of Cancer and Clinical Oncology. 22:245-249
The activity of menogaril and its major metabolite in animals and humans, N-demethylmenogaril, has been investigated in the human stem cell assay as developed by Salmon et al. Among 31 evaluable samples, four were sensitive to menogaril, including on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::931dd32517445c9f05d604370cc9b202
https://doi.org/10.1016/0277-5379(86)90387-1
https://doi.org/10.1016/0277-5379(86)90387-1
Autor:
Charlotte Sanders, William Rombaut, Jean Klastersky, Nadine Crespeigne, Yvon Kenis, Marcel Rozencweig, Genevieve Decoster
Publikováno v:
Investigational New Drugs. 2:267-270
The anticancer activity of carminomycin was investigated in a human tumor cloning assay. No efficacy could be identified in the WiDr and the MCF7 cell lines which were highly responsive to doxorubicin. In addition, drug testing experiments were carri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44a8ccde846b5a234d3ab937199712d4
https://doi.org/10.1007/bf00175375
https://doi.org/10.1007/bf00175375
Autor:
Pierre Dodion, E. Cumps, Charles Nicaise, D. Kisner, Martine Piccart, Marcel Rozencweig, Yvon Kenis, N. Crespeigne
Publikováno v:
European Journal of Cancer and Clinical Oncology. 18:519-522
Twenty-three patients with advanced solid tumors received 9 -hydroxy- 2N -methyl-ellipticinium acetate at a single daily i.v. dose of 15–80 mg/m 2 for 5 consecutive days , repeated every 3 weeks . One partial and one minor response were achieved in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::954cf2d241db05f1df82998677fefd3c
https://doi.org/10.1016/0277-5379(82)90220-6
https://doi.org/10.1016/0277-5379(82)90220-6
Autor:
J. Joggi, Dominique de Valeriola, F. Wery, Yvon Kenis, Pierre Dodion, N. Crespeigne, B. Peeters, C. Van Berchem
Publikováno v:
Acta Oncologica. 27:517-520
Eighteen adult patients with solid tumors were treated with oral menogaril, a new anthracycline antibiotic active against human breast cancer after intravenous administration. The drug was given orally on 3 consecutive days every 4 weeks at doses ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00391be551a831521d6731b02586d582
https://doi.org/10.3109/02841868809093580
https://doi.org/10.3109/02841868809093580
Autor:
J. Lustman-Maréchal, G. Achtent, L. Texier, Delaunay M, Perrot H, Rose-Marie Durepaire, Michel Prunieras, Puissant A, R. Touraine, Joseph Wybran, Delanoë J, K. Konrad, Jean Thivolet, Yvon Kenis, Marie-Ange Tousch, Pierre Souteyrand, R. Denepoux, C. de Bast, Jean Revuz, B. van den Heule, A. Alario, R. Regnier, R. Heimann, G. Storme, Jean H. Saurat, Georges Achten, D. Schmitt
Publikováno v:
Dermatology. 157:I-VI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a588bccfbcaec1ae40ac4bcfc310456
https://doi.org/10.1159/000250854
https://doi.org/10.1159/000250854
Autor:
Yvon Kenis, J. Michel, D. Balikdjian, Vanderhoeft P, H. Bondue, Otilia Dalesio, J. Wybran, P. Van Houtte, P. Rocmans
Publikováno v:
European Journal of Cancer (1965). 16:1597-1601
Since 1976, a double blind study has been conducted to assess the value of levamisole as adjuvant treatment to surgery for non-small cell carcinoma of the lung. Fifty-one patients were evaluable with a minimal follow-up period of 1 yr. No difference
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3b990a98ea5bbc40ce5c40f3ab83827
https://doi.org/10.1016/0014-2964(80)90033-x
https://doi.org/10.1016/0014-2964(80)90033-x
Publikováno v:
Investigational New Drugs. 1:309-313
4'-Deoxydoxorubicin is a new anthracycline derivative. Experimentally, the drug shows efficacy against doxorubicin-resistant malignancies and, as compared to the parent compound, it has reduced potential for heart damage. This Phase I trial was condu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61d09364a8739e9d223b00787b1512f3
https://doi.org/10.1007/bf00177414
https://doi.org/10.1007/bf00177414